Healthify swallowed its disruptors. But can it digest them?

About this episode

The episode discusses Healthify's challenges with AI and appetite-suppressing drugs, featuring insights from its CEO and a professor.

Most businesses die quietly. They miss a wave, lose relevance and fade out. Healthify nearly got hit by two in quick succession. First, AI that could do what took the company years to build. Then, a drug which meant you didn't need the discipline anymore. So Rahel Philipose and Praveen Gopal Krishnan asked Tushar Vashisht , Healthify's co-founder and CEO, the uncomfortable question directly: if anyone can build an AI coach and a drug can kill your appetite, what exactly are you selling? This episode is really about three things most people don't know. One, why people who take Ozempic without a lifestyle program gain almost all the weight back within a year. Two, what actually happens to a platform business when AI replaces one entire side of it. And three, why Tushar believes his most dangerous competitor hasn't been founded yet. We were also joined by Professor R Srinivasan from IIM Bangalore, who had a very different read on whether Healthify's bet is genius or cope. ______ This episode was produced by Uddantika Kashyap and mixed and mastered by Rajiv CN, our resident sound engineer. If you liked this episode, share it with your friends, family and colleagues. And if you have…

People in this episode

Hosts: Rahel Philipose, Praveen Gopal Krishnan

Guests: Tushar Vashisht, Professor R Srinivasan

Topics covered

• AI in business
• health and wellness
• weight management
• platform business challenges
• competitive analysis

Keywords

• Healthify
• AI coach
• Ozempic
• weight loss
• platform business
• Tushar Vashisht
• lifestyle program

Mentioned in this episode

Organizations: Healthify, IIM Bangalore, The Ken

Products: Ozempic

More episodes of Two by Two

• Groww beat every odd to get here. What beats it next? · May 14, 2026 · 1h 4m
• Should young designers pay senior designers to teach them? · May 7, 2026 · 1h 15m
• Hyrox gave India a finish line. What happens after you cross it? · April 30, 2026 · 1h 9m
• Why do India’s gig workers love a job they’re desperate to leave? · April 23, 2026 · 1h 14m
• Can NPCI's BHIM take on the giants it created? · April 9, 2026 · 1h 4m
• 19 years on, is IPL still too big to fail? Sharda Ugra answers · April 2, 2026 · 1h 10m